Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:NBIX’

Howard Marks OAKTREE CAPITAL MANAGEMENT

Hedge Funds Are Dumping Neurocrine Biosciences, Inc. (NBIX)

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating......(read more)
Kris Jenner - Rock Springs Capital

Did Hedge Funds Drop The Ball On Neurocrine Biosciences, Inc. (NBIX) ?

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due......(read more)
CITADEL INVESTMENT GROUP

Should You Buy Neurocrine Biosciences, Inc. (NBIX)?

During the first half of the fourth quarter the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by about 4 percentage points as investors......(read more)
Phongphan/Shutterstock.com

Market Movers Today: Devon Energy Corp (DVN), Vonage Holdings Corp. (VG), Quad/Graphics, Inc. (QUAD), La-Z-Boy Incorporated (LZB), and More

Devon Energy Corp (NYSE:DVN) (MarketWatch) Shares of Devon Energy Corp. DVN, -10.16% fell 6% in premarket trading Wednesday, after the company posted......(read more)
Pressmaster/Shutterstock.com

13G Filing: Perceptive Advisors and Neurocrine Biosciences Inc (NBIX)

Neurocrine Biosciences Inc. (NASDAQ:NBIX): Joseph Edelman’s Perceptive Advisors filed an amended 13D. You can check out Perceptive Advisors’......(read more)
stock, market, buy, graph, risk, trading, dice, concepts, chart, objects, investment, opportunity, business, three-dimensional, horizontal, line, gambling, decisions, symbol,

Check Out These 34 Stories To Find Out What’s Happening In The Financial Markets Today

1. U.S. Stock Market: “U.S. equities traded higher on Wednesday as investors cheered the Federal Reserve’s plan for scaling back its massive......(read more)
Stock Trading, Performance, Stock Analysis

23 Key Stories That Are Shaking Up The Finance World Today

1. US Stock Market:   “U.S. equities fell on Wednesday as investors assessed the geopolitical landscape. The Dow Jones industrial average fell......(read more)
Wall Street Bull

Neurocrine Biosciences, Inc. (NBIX) Surges After FDA Gives Green Light to Ingrezza

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) have popped 22% in extended market trading after the FDA approved INGREZZA for the treatment of......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here Are Two Market Moving Biotech Catalysts To Watch This Week

The biotechnology sector is in full swing for the New Year, and while the JP Morgan conference is now in the rearview mirror, there are still plenty of......(read more)
people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

What Does The Panel Cancellation Mean For Neurocrine Biosciences, Inc. (NBIX)?

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) just announced that that the FDA has cancelled the Psychopharmacologic Drugs Advisory Committee meeting for......(read more)
biotech, molecular, soil, scientist, closeup, experiment, goggles, workwear, biologist, protective, researching, green, sprout, molecules, formula, eco, future, sample,

Is Neurocrine Biosciences, Inc. (NBIX) a Good Stock to Buy?

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed

Joseph Edelman‘s Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being......(read more)
Jeffrey Ray - Great Point Partners

This Biotech Hedge Fund’s Stock Picks Killed It in Q3

Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again. Hedge fund investors have been withdrawing their capital......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, internet, male, drugstore, service,

Here’s Our Take On Neurocrine Biosciences, Inc. (NBIX)’s Ingrezza

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) just notified markets that the FDA has accepted a new drug application (NDA) for its lead drug candidate, Ingrezza......(read more)
medications-pharmacy drugs

Blue Jay Capital Betting On Big Returns From These Healthcare Stocks

Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California. Prior to founding Blue Jay......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Top Biotech Picks of Best-Performing Hedge Fund of 2015

Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top......(read more)
Cheniere LNG Tanker Shipping Ship Liquid Natural Gas Vessel Fuel Carrier

Four Stocks Driving Thursday’s Market Gains: How Did They Do It?

In the first eight days of the year, the S&P 500 index fell by roughly 7.5%, the Dow lost 7.3%, and the NASDAQ tumbled by 9.6%. However, the markets......(read more)
Syda Productions/Shutterstock.com

Hedge Funds Growing Fond Of Neurocrine Biosciences, Inc. (NBIX)

Is Neurocrine Biosciences, Inc. (NASDAQ:NBIX) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive......(read more)
Amicus Therapeutics

Amicus Therapeutics, Inc. (FOLD), Neurocrine Biosciences, Inc. (NBIX), and Retrophin Inc (RTRX) among Biotech Guru Joseph Edelman’s Top Healthcare Picks

Biotech Guru Joseph Edelman‘s Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks. Edelman founded......(read more)
Sergey Nivens/shutterstock.com

More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks

The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds......(read more)
Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?

Should Pacira Pharmaceuticals Inc (NASDAQ:PCRX) investors track the following data? To the average investor, there are many methods market participants......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week

In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they’re hot like summer, sometimes they’re dormant......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Inovio Pharmaceuticals Inc (INO), ISIS Pharmaceuticals, Inc. (ISIS): This Week in Biotech

With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Why Neurocrine Biosciences, Inc. (NBIX) Shares Imploded

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

AbbVie Inc (ABBV), AstraZeneca plc (ADR) (AZN): Neurocrine Biosciences, Inc. (NBIX) Nosedives on Mid-Stage Study Results

Investors hate to wake up and find that one of their stocks has opened nearly 30% lower than the prior day’s close. Unfortunately, that’s......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)

Is it smart to be bullish on Neurocrine Biosciences, Inc. (NASDAQ:NBIX)? In the financial world, there are dozens of indicators investors can use to......(read more)
Impax Laboratories Inc (NASDAQ:IPXL)

Hedge Funds Are Buying Impax Laboratories Inc (IPXL)

Is Impax Laboratories Inc (NASDAQ:IPXL) a good investment? At the moment, there are tons of indicators shareholders can use to analyze publicly traded......(read more)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a good investment? In the eyes of many investors, hedge funds are seen as useless, outdated investment tools......(read more)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?

To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are......(read more)
Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)

Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood. The number of long hedge fund positions......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds’ portfolio at the end of the first quarter of 2013. NBIX has experienced an increase......(read more)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Hedge Funds Are Betting On Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors should pay attention to an increase in hedge fund interest in recent months. According to most shareholders......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Here is What Hedge Funds Think About Neurocrine Biosciences, Inc. (NBIX)

Is Neurocrine Biosciences, Inc. (NASDAQ:NBIX) a buy right now? The smart money is in a pessimistic mood. The number of long hedge fund positions shrunk......(read more)

Hedge Funds Are Buying Aegerion Pharmaceuticals, Inc. (AEGR)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds’ portfolio at the end of the fourth quarter of 2012. AEGR has seen an increase......(read more)

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?: Impax Laboratories Inc (IPXL), Pacira Pharmaceuticals Inc (PCRX)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds’ portfolio at the end of December. AEGR has experienced an increase in enthusiasm......(read more)

Endocyte, Inc. (NASDAQ:ECYT), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH): Should You Avoid Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)?

Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) a safe stock to buy now? Prominent investors are in a bearish mood. The number of long hedge fund bets dropped......(read more)
Aetna Inc. (NYSE:AET)

Aetna Inc. (AET), Rosetta Stone Inc (RST) & More: Three Stocks Near 52-Week Highs Worth Selling

Yesterday’s Automatic Data Processing (NASDAQ:ADP) employment data may not have struck a chord with optimists, and North Korean tensions appear......(read more)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Hedge Funds Aren’t Crazy About Neurocrine Biosciences, Inc. (NBIX) Anymore: Keryx Biopharmaceuticals (KERX), Rigel Pharmaceuticals, Inc. (RIGL)

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 12 hedge funds’ portfolio at the end of December. NBIX shareholders have witnessed a decrease......(read more)
Dendreon Corporation (NASDAQ:DNDN)

3 Humongous Health-Care Stocks This Week: Dendreon Corporation (DNDN), Neurocrine Biosciences, Inc. (NBIX)

As millions of Americans brace themselves for a massive blizzard, a handful of health-care stocks have been heating up the charts over the past few days......(read more)